United States, ex rel., Witkin, et al. v. Medtronic, Inc., et al.

  1. June 05, 2024

    Medtronic Can't Pause FCA Claims For 1st Circ. Detour

    A Massachusetts federal judge on Wednesday declined to pause a long-pending False Claims Act and whistleblower retaliation case against medical device maker Medtronic so it can appeal a recent ruling, saying the court and the parties need to "get it moving."

  2. April 11, 2024

    Medtronic Can't Ditch Ex-Sales Rep's Retaliation Claim

    Medical device maker Medtronic can't avoid a whistleblower retaliation claim by a former sales rep who says he was pushed out after reporting what he suspected to be a kickback scheme to the U.S. Food and Drug Administration, a federal judge said Wednesday.

  3. December 11, 2023

    Medtronic Says Promotions Not Basis For FCA Case

    Medical device maker Medtronic struggled Monday to convince a Boston federal judge that its practice of staffing representatives at doctors' offices to help patients get set up with its glucose monitors and insulin pumps is an allowable promotion for the company to offer and not an illegal kickback under the False Claims Act.

  4. October 19, 2016

    Relator Pulls State Insurance Fraud Claim Against Medtronic

    An ex-Medtronic Inc. sales rep who alleges his former employer paid doctors kickbacks won't pursue California and Illinois based private insurance fraud claims in Massachusetts federal court, dismissing them without prejudice there but leaving the option to file again somewhere else.

  5. August 12, 2016

    Medtronic Seeks To Nix State-Law Claims In FCA Suit

    Medtronic Inc. urged a Massachusetts federal judge Friday to peel allegations brought under California and Illinois private insurance fraud statutes from a False Claims Act suit, contending that the relator's claims lack a number of necessary facts, including the name of any insurer supposedly defrauded.

  6. May 24, 2016

    Medtronic Can't Shake FCA Kickback Claims

    A Massachusetts federal judge said Monday he would let most of a False Claims Act suit against Medtronic Inc. go through, including allegations of kickbacks and whistleblower retaliation, but dismissed claims regarding improper off-label promotion.

  7. January 08, 2013

    Medtronic Wants Off-Label Marketing FCA Suit Junked

    Medtronic Inc. asked a Massachusetts federal judge Monday to stamp out a whistleblower's False Claims Act suit alleging it provided kickbacks and promoted off-label uses of insulin pumps, saying that even if improper marketing took place, it did not mean Medicare and Medicaid were defrauded.